AlbionVC exits Clear Review after a strategic acquisition by Advanced. AlbionVC led Clear Review's Series A investment in 2019 and today is pleased to see the company embark on the next stage of growth.
Christoph Ruedig, AlbionVC Partner reflects on how technology is driving innovation and change within clinical trials.
Elliptic, Quantexa and Speechmatics named among the 25 fastest growing technology businesses in the UK.
AlbionVC has secured 3 nominations in GP. Bullhound Investor Allstars 2020 for venture capital fund of the year, exit of the year and Ed Lascelles, Partner at AlbionVC as investor of the year.
Odin Vision, a UCL Technology Fund portfolio company has received a grant to accelerate its cutting edge AI technology to fight bowel cancer. Odin Vision’s technology assists doctors to detect and characterise cancerous and pre-cancerous polyps during colonoscopy procedures.
Jay Wilson, Investment Manager at AlbionVC reflects on the impact of Covid-19 on M&A activity in fintech and discusses how his view has changed from the start of the pandemic to now. More on the story in FintechFutures.